We believe that providing information to the public about our company, our medicines and how we do business serves the best interests of patients.
The medicines we discover and develop and the interactions we have play an integral role in the US healthcare system. We view the way we conduct our business as a great responsibility for our company and all of our employees, and it is critically important to us that the public trusts our ability to carry out this responsibility ethically and in the best interest of patient health.
We hope that by being open about how we conduct our business, about the safety and risks of our medicines, about our interactions with health care professionals, and our relationships with key stakeholders and partners in the community, we can help to earn this trust and continue with our mission of helping to improve patients’ health through meaningful medicines.
You will find links to information on our efforts below:
-
AZ on the Issues: Learn how we are working with health care professionals, patient advocacy groups and policymakers to find solutions to some of the complex health issues facing Americans today
-
Community Support: Learn how we partner with nonprofit organizations to achieve the shared goal of helping people to live longer, healthier lives, and view a national listing of our contributions to nonprofit organizations
-
Compliance Program: Find details about AstraZeneca’s US Compliance Program, and learn how we are ensuring the highest standards of conduct in all our operations
-
Clinical Trials: View details of new and ongoing clinical trials sponsored by AstraZeneca
-
Independent Medical Education Grants: View biannual reports of our independent medical education grants to educational provider organizations
-
Political Contributions: View quarterly reports of all political contributions made by our employee Political Action Committee (AZPAC), and learn how AstraZeneca is committed to participating in the political process as a responsible corporate citizen
-
Postmarketing Study Commitments: View a summary of clinical and preclinical commitments that are currently active for AstraZeneca products
Beginning in 2010, AstraZeneca will also begin reporting compensation to healthcare professionals who speak on behalf of our company and products in the United States. Click here to learn more.
